Mc Gowan Group Asset Management, Inc. Gilead Sciences, Inc. Transaction History

Mc Gowan Group Asset Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$73.27 - $83.09 $184,127 - $208,805	2,513 New	2,513 $203,000
Q2 2023 Aug 09, 2023	BUY	$76.01 - $86.7 $1,292 - $1,473	17 Added 0.63%	2,727 $210,000
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $3,324 - $3,787	43 Added 1.61%	2,710 $224,000
Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $166,207 - $238,616	2,667 New	2,667 $228,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Mc Gowan Group Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Mc Gowan Group Asset Management, Inc. with notifications on news.